Glucotrack's Lōkahi Therapeutics Announces Expansion Of ai² Platform Into Three Divisions: ai² Pipeline, ai² Talent, And ai² Accelerator; Says Platform Now Spans 13 Universities, Has Evaluated More Than 45 Therapeutic Assets

Loading news article.

Glucotrack's Lōkahi Therapeutics Announces Expansion Of ai² Platform Into Three Divisions: ai² Pipeline, ai² Talent, And ai² Accelerator; Says Platform Now Spans 13 Universities, Has Evaluated More Than 45 Therapeutic Assets | WAPE

Glucotrack's Lōkahi Therapeutics Announces Expansion Of ai² Platform Into Three Divisions: ai² Pipeline, ai² Talent, And ai² Accelerator; Says Platform Now Spans 13 Universities, Has Evaluated More Than 45 Therapeutic Assets

Article summary

Related companies

Comments —